News

PureTech Health plc, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, announced that it has entered into a research…
Read More...

CASI Pharmaceuticals, a U.S. pharmaceutical company with a platform to develop and accelerate the launch of innovative therapeutics and pharmaceutical products in China, the U.S., and…
Read More...

STC Biologics (www.stcbiologics.com) announced that it has completed construction of a single-use mammalian GMP manufacturing facility in Newton, Massachusetts, and that it has…
Read More...

I-Mab Biopharma, a biotech company focusing exclusively on innovative biologics in immuno-oncology and auto-immune diseases, and WuXi Biologics, a leading global open-access biologics…
Read More...

Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards programme to fast track drug…
Read More...

MS Pharma, a fast growing pharmaceutical company based in Jordanand operating across the Middle East, Turkey and Africa, announced that it has entered into an agreement to acquire 100%…
Read More...

Recro Pharma, a specialty pharmaceutical company with a high-performing revenue generating contract development and manufacturing (CDMO) division, announced that Recro Gainesville LLC,…
Read More...

Gilead Sciences Inc. and insitro announced today that the companies have entered into a strategic collaboration to discover and develop therapies for patients with nonalcoholic…
Read More...

Greenfield Global Inc., Canada's largest producer of alcohol and fuel ethanol, and one of the largest alcohols and solvents companies in North America, has announced plans to establish…
Read More...

Fibrocell Science announced the completion of a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007,…
Read More...

Adare Pharmaceuticals announced that it has entered into an agreement with Egalet Corporation, to acquire global rights of the “Parvulet” technology platform and its associated…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) accepted the company's Biologics License Application (BLA) for brolucizumab (RTH258) for the treatment of wet…
Read More...

Alnylam Pharmaceuticals announced that the Company has initiated ILLUMINATE-B, a global Phase 3 pediatric study of lumasiran, an investigational, subcutaneously administered RNAi…
Read More...

San Diego-based Allele Biotechnology and Pharmaceuticals, Inc., officially announced a joint research and development agreement with South Korea’s SCM Lifescience Co., Ltd., for the…
Read More...

DNAnexus, Inc., and the not-for-profit Sutter Health network announced the first large-scale clinico-genomic multiple sclerosis (MS) research study conducted by a leading healthcare…
Read More...

Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, announces it has entered a public-private partnership with the…
Read More...

Pulmatrix and Cipla Technologies announced their entry into a Definitive Agreement for the co-development and commercialization of Pulmazole (PUR1900) – an inhaled iSPERSE formulation…
Read More...

Boehringer Ingelheim has acquired a minority stake in SoundTalks NV, a Belgian company. SoundTalks NV has developed a digital monitoring tool that seeks to improve the healthcare of…
Read More...

Catalent and Paragon Bioservices announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion. “Paragon’s unparalleled expertise…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that it has entered into a definitive agreement to acquire a portfolio of 42 approved, non-marketed Abbreviated New Drug Applications (ANDAs) in…
Read More...